Cardio Diagnostics Holdings, Inc., listed under the ticker MAAQ, filed a Form 10-Q with the Securities and Exchange Commission on May 12, 2022. MAAQ is associated with Mana Capital Acquisition Corp., a blank-check special purpose acquisition company that completed its initial public offering in 2021 targeting opportunities in the healthcare and diagnostics sector, with a specific focus on cardiovascular diagnostics. At the time of this quarterly filing, the SPAC was in active pursuit of its business combination, positioning itself within a life-sciences niche with strong secular demand for non-invasive cardiac testing. Sign up at SpacDesk for complete filing history, deal timelines, and SPAC-specific analytics on MAAQ and the broader universe of transactions.